News Headline: National Lung Cancer Partnership is Now Free to Breathe, Continues Commitment to Double Five-Year Lung Cancer Survival By 2022
Outlet Full Name: Sacramento Bee
Author: No author
MADISON, Wis., Feb. 4, 2014 — /PRNewswire-USNewswire/ — Changing its name – but not its focus – the National Lung Cancer Partnership is now Free to Breathe, a name that conveys the organization’s passion, dedication and vision to double lung cancer survival by 2022, empower advocates and help every person affected by the disease.
“Free to Breathe resonates deeply with people whose lives have been affected by lung cancer, and it embodies who we are and what we do,” said Joan H. Schiller, M.D., president of Free to Breathe and chief of hematology/oncology at the University of Texas Southwestern Medical Center, Dallas. “We believe that every lung cancer patient deserves a cure, and we will not rest until the movement reaches the critical mass necessary to make this a reality.”
People across the country are familiar with the name Free to Breathe, the long-time moniker for the organization’s nationwide fundraising and awareness event series, including walks, runs, bike rides and yogathons. Since it’s inception in 2006, the event series has raised more than $10 million with 100 percent of the net proceeds directly funding research and patient programs crucial to increasing survival. For information about upcoming events, visit www.freetobreathe.org/get-involved.
As Free to Breathe, the organization will continue its work towards the elimination of lung cancer, which claims more than 160,000 lives in the United States every year – more than any other cancer, and more than breast, colon and prostate cancers combined. Free to Breathe is committed to doubling survival by 2022 because the five-year lung cancer survival rate has increased only slightly in a decade, from 15 percent to 16 percent.
“Free to Breathe is an organization powered by people who are committed to forever changing what it means when a family faces a lung cancer diagnosis,” said Regina Vidaver, Ph.D., executive director of Free to Breathe. “Our programs, resources and events are poised to inspire and empower, propelling the movement like never before to double lung cancer survival.”
To double lung cancer survival by 2022, Free to Breathe focuses on accelerating research, helping patients understand treatment options and ensuring patients benefit from innovative therapies that save lives.
To learn more and become involved in Free to Breathe’s vision to double lung cancer survival visit www.freetobreathe.org
Free to Breathe
Free to Breathe, a 501(c)(3) non-profit organization, is a partnership of lung cancer survivors, advocates, researchers, healthcare professionals and industry leaders dedicated to doubling lung cancer survival by 2022. For more information, visit www.freetobreathe.org.